Wolverine Asset Management LLC Organon & Co. Put Options Transaction History

Wolverine Asset Management LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 13, 2024	SELL	$13.78 - $18.8 $392,730 - $535,800	-28,500 Reduced 97.27%	800 $15,000
Q4 2023 Feb 01, 2024	BUY	$10.95 - $17.32 $14,234 - $22,516	1,300 Added 4.64%	29,300 $422,000
Q3 2023 Nov 13, 2023	BUY	$16.59 - $23.77 $393,183 - $563,349	23,700 Added 551.16%	28,000 $486,000
Q2 2023 Aug 07, 2023	BUY	$19.27 - $24.63 $50,102 - $64,038	2,600 Added 152.94%	4,300 $89,000
Q1 2023 May 08, 2023	BUY	$21.42 - $32.08 $34,272 - $51,328	1,600 Added 1600.0%	1,700 $39,000
Q4 2022 Feb 01, 2023	BUY	$23.31 - $28.61 $2,331 - $2,861	100 New	100 $2,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.75B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Asset Management LLC with notifications on news.